Activation of the insulin-like growth factor-binding protein-5 promoter in osteoblasts by cooperative E box, CCAAT enhancer-binding protein, and nuclear factor-1 deoxyribonucleic acid-binding sequences

Endocrinology

Volumn 140, Issue 10, 1999, Pages 4564-4572

  Ji, C ^a   Chen, Y ^a   Centrella, M ^a   McCarthy, T L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; DNA; NUCLEAR FACTOR I; PROSTAGLANDIN E2; SOMATOMEDIN BINDING PROTEIN 5;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; ELECTROPHORETIC MOBILITY; FETUS; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; RAT; SEQUENCE ANALYSIS;

EID: 0033305609     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.10.7061     Document Type: Article

References (60)

1. Growth factor modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cells
2. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent
3. 2, growth hormone, and the insulin-like growth factors
4. Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells
5. Parathyroid hormone and parathyroid hormone-related peptide stimulate insulin-like growth factor-binding protein secretion by rat osteoblast-like cells through a adenosine 3',5'-monophosphate-dependent mechanism
6. Differentiation of MC3T3-E1 osteoblasts is associated with temporal changes in the expression of IGF-I and IGFBPs
7. Insulin-like growth factors and their binding proteins: Biological actions
8. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I
9. Comparison studies of IGFBP-5 binding to osteoblasts and osteoblast-derived extracellular matrix
10. Insulin-like growth factor binding proteins localize to discrete cell culture compartments in periosteal and osteoblast cultures from fetal rat bone
11. A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells
12. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiaties IGF action
13. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells
14. Identification of five different insulin-like growth factor bonding proteins (IGFBPs) for adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human
15. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone
16. Insulin-like growth factor binding protein proteolysis in bone cell models
17. Characterization of insulin-like growth vactor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation
18. Plasmin degradation of insulin-like growth factor-binding protein-5 (IGFBP-5): Regulation by IGFBP-5 (201-218)
19. Regulation and biological effect of endogenous insulin-like growth factor binding protein-5 in human osteoblastic cells
20. Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures
21. 2-treatment
22. Heparin, heparin sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes
23. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells
24. Phosphorylation of insulin-like growth factor binding proteins
25. Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells
26. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells
27. 2 in primary rat osteoblasts
28. 2 in osteoblast cells
29. Structure and function of the mouse insulin-like growth factor binding protein 5 gene promoter
30. Further biochemical and molecular characterization of primary rat parietal bone cell cultures
31. Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA
32. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2
33. 2 in osteoblasts
34. A small scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing
35. CCAAT/enhancer binding protein δ activates insulin-like growth factor-I gene transcription in osteoblasts
36. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression
37. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription
38. Defining the regulatory networks for muscle development
39. cAMP-dependent protein kinase represses myogenic differentiation and the activity of the muscle-specific helixloop-helix transcription factors Myf-5 and MyoD
40. An adipogenic basic helix-loop-helix-leucine zipper type transcription factor (ADD1) mRNA is expressed and regulated by retinoic acid in osteoblastic cells
41. Sclerotome-related helix-loop-helix type transcription factor (scleraxis) mRNA is expressed in osteoblasts and its level is enhanced by type-beta transforming growth factor
42. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist
43. Transcriptional activation by Myc is under negative control by the transcription factor AP-2
44. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E-box-related sites in vivo
45. Interaction of the co-activator CBP with Myb proteins: Effects on Myb-specific transactivation and on the cooperativity with NF-M
46. E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein
47. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms
48. The helix-loop-helix transcription factor USF interacts with the basal promoter of human amyloid precursor protein
49. Identification of a DNA sequence involved in osteoblast-specfic gene expression via interaction with helix-loop-helix (HLH)-type transcription factors
50. Developmental regulation of osteocalcin expression in MC3T3-E1 osteoblasts: Minimal role of the proximal E-box cis-acting promoter elements
51. An E-box within the prostaglandin endoperoxide synthase-2 (PGS-2) promoter is required for transcription in rat ovarian granulosa cells
52. Transcription of the transforming growth factor-β2 gene is dependent on an E-box located between an essential cAMP response element/activating transcription factor motif and the TATA box of the gene
53. Binding of upstream stimulatory factor to an E-box in the 3'-flanking region stimulates α1(I) collagen gene transcription
54. Characterization of the chromosomal gene and promoter for human insulin-like growth factor binding protein-5
55. Cloning of the rat insulin-like growth factor binding protein-5 gene and DNA sequence analysis of its promoter region
56. Cell-specific regulation of IRS-1 gene expression: Role of E-box and C/EBP binding site in HepG2 cells and CHO cells
57. Hormonal regulation of the rat class I alcohol dehydrogenase gene
58. Autoregulation of the human C/EBPα gene by stimulation of upstream stimulatory factor binding
59. The helix-loop-helix protein rE12 and the C/EBP-related factor rNFIL-6 bind to neighboring sites within the c-Fos serum response element
60. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone